Medindia

X

TPI Receives Production License for Its Anti-diabetic Drug Gliclazide Tablets from China's SFDA

Wednesday, June 1, 2011 General News J E 4
Advertisement

Tel:            

+86-28-8551-6696 (Chengdu, China)

+86-134-3655-0011 (China)

Address:  

23rd Floor, Unionsun Yangkuo Plaza

No. 2, Block 3, South Renmin Road

Chengdu, 610041

China

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Nektar Therapeutics' President and CEO Howard W. R...
S
NTT DATA Extends DATATRAK Relationship